Breakthrough pill for treating prostate cancer

Fall 2008 CSANews Issue 68  |  Posted date : Sep 19, 2008.Back to list

A breakthrough prostate cancer drug, called abiraterone, may be available for general use by 2011. Researchers at the Royal Marsden Hospital in London, England, where the drug was discovered, have found that abiraterone can shrink tumours in up to 80 per cent of those with aggressive forms of prostate cancer. As part of the study, patients took four pills per day and reported very few side effects. This is in stark contrast to the damaging effects of chemotherapy and radiation. Researchers hope that abiraterone will eventually offer patients with aggressive forms of prostate cancer an effective method for managing their condition and for prolonging their lives. At this time, however, the drug is available through clinical trials only.